| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306573A Novel human thrombopoietin mutein |
| 08/01/2001 | CN1306512A Heterocyclic inhibitors of P38 |
| 08/01/2001 | CN1306089A Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases |
| 08/01/2001 | CN1306007A Dry cell factor |
| 08/01/2001 | CN1305989A Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 08/01/2001 | CN1305836A Medicine for treating epistaxis |
| 07/31/2001 | US6268483 Taking blood sample from patient, harvesting solution wich contains fibrin monomer, prothrombin, and factor xiii in certain concentrations, then forming fibrin polymer; for use in same patient |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268391 Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases |
| 07/31/2001 | US6268379 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 07/31/2001 | US6268360 Urination delay |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268342 Method of inhibiting fibrosis with a somatostatin agonist |
| 07/31/2001 | US6268341 These polypeptides are useful for treating diseases wherein antagonism of hupar is therapeutically beneficial. |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/31/2001 | CA2069428C A mammalian cytokine, il-11 |
| 07/31/2001 | CA2041240C Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds |
| 07/26/2001 | WO2001053541A1 Antisense modulation of caspase 8 expression |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053328A1 Process for the purification of antothrombin-iii |
| 07/26/2001 | WO2001053310A1 Antisense modulation of caspase 3 expression |
| 07/26/2001 | WO2001053285A1 Food product and process |
| 07/26/2001 | WO2001053280A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 07/26/2001 | WO2001053267A1 Compounds exhibiting thrombopoietin receptor agonism |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001052865A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | WO2001052847A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | WO2001052836A1 Intravenous carnitine for the treatment of chronic uraemic patients undergoing periodical dialysis |
| 07/26/2001 | WO2001052745A1 Novel dyes |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | US20010009915 Nitrogen oxide yielding and thromboxane A2 (TXA2) and serotonin (5HT2) receptor antagonist; treatment of atherothrombotic cardiovascular disorders |
| 07/26/2001 | DE10002510A1 New phenylamidine compounds are useful for the treatment of thrombosis, cerebrovascular disorders, heart infarction, arteriosclerosis, osteoporosis, tumor metastasis, shock and diabetes |
| 07/26/2001 | DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders |
| 07/26/2001 | CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production |
| 07/26/2001 | CA2397665A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | CA2397627A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | CA2397565A1 Food product and process |
| 07/26/2001 | CA2397533A1 Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparation thereof |
| 07/26/2001 | CA2397202A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | CA2395489A1 Process for the purification of antothrombin-iii |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2332214A1 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 07/25/2001 | EP1118610A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/25/2001 | EP1117793A2 Secretory protein - zsig48 |
| 07/25/2001 | EP1117765A2 Stem cells bearing an fgf receptor on the cell surface |
| 07/25/2001 | EP1117762A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 07/25/2001 | EP1117684A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 07/25/2001 | EP1117664A1 Imidazo[4,5-c-]-pyridine-4-one derivatives with factor xa inhibiting effect |
| 07/25/2001 | EP1117660A1 Thrombin inhibitors |
| 07/25/2001 | EP1117644A1 Benzamide derivatives as thrombin inhibitors |
| 07/25/2001 | EP1117643A1 New crystal modification iii of torasemide |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP1117441A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/25/2001 | EP1117437A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 07/25/2001 | EP1117419A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/25/2001 | EP1117406A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117396A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 07/25/2001 | EP1117389A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 07/25/2001 | EP0826004B1 Storage stable hemoglobin solutions |
| 07/25/2001 | CN1305494A Antithrombotic compounds |
| 07/25/2001 | CN1305492A Phrazinone protease inhibitors |
| 07/25/2001 | CN1305483A Polymorphic clopidogrel hydrogenesulphate form |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305470A Amidine compounds |
| 07/25/2001 | CN1305342A Methods for reducing levels of homocysteine and C-reactive protein |
| 07/25/2001 | CN1305108A Medicine screen model for screening and evaluating activity of thrombocyte and process for preparing reagent and medicine respectively for diagnosing and treating thrombocyte disease |
| 07/25/2001 | CN1305003A Gene engineering process for preparing died/tried fusion protein of erythrocyte growth factor with improved bioactivity |
| 07/25/2001 | CN1304687A Se-enriched cordyceps militaris tea and its preparing process |
| 07/25/2001 | CN1068791C Hizoma imperatae white gourd tea |
| 07/25/2001 | CN1068778C Drag composition for treating and curing and its preparing method |
| 07/24/2001 | US6265575 Thrombin inhibitors |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265416 Anticoagulants |
| 07/24/2001 | US6265404 Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
| 07/24/2001 | US6265397 Amidino derivatives and their use as thrombin inhibitors |
| 07/24/2001 | US6265378 Protein Z-dependent protease inhibitor |
| 07/24/2001 | US6265184 Polynucleotides encoding chemokine receptor 88C |
| 07/24/2001 | US6264990 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity. |
| 07/24/2001 | US6264988 Reduce bleeding time in animal |
| 07/24/2001 | US6264978 Transdermal application system containing acetylsalicylic acid for antithrombotic therapy and cancer prophylaxis |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264938 Administering polydiallylamine and hydroxy-3-methylglutaryl/3-/, coenzyme a reductase |
| 07/24/2001 | CA2331847A1 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 07/24/2001 | CA2193454C Bioadhesive pharmaceutical composition for the controlled release of active ingredients |
| 07/24/2001 | CA2085465C Thrombin inhibitors based on the amino acid sequence of hirudin |
| 07/24/2001 | CA2027936C Cyclic anti-aggregatory peptides |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051510A2 G-csf conjugates |
| 07/19/2001 | WO2001051484A1 Benzimidazole derivatives and their use as factor xa inhibitors |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051454A1 Compounds and compositions for delivering active agents |